RecruitingNot applicableNCT06587841

Noninvasive Spinal Cord Stimulation for Early SCI

Studying Rare autonomic nervous system disorder

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of British Columbia
Principal Investigator
Andrei Krassioukov, MD,PhD,FRCPC
The University of British Columbia, International Collaboration on Repair Discoveries (ICORD)
Intervention
Spinal COrd NEuromodulation™ (SCONE™) for transcutaneous spinal cord stimulation (TSCS)(device)
Enrollment
60 target
Eligibility
19-65 years · All sexes
Timeline
2024 – 2027

Study locations (1)

Collaborators

United States Department of Defense · Rivne Regional War Veterans Hospital, Spinal Cord Injury Rehabilitation Center · Congressionally Directed Medical Research Programs

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06587841 on ClinicalTrials.gov

Other trials for Rare autonomic nervous system disorder

Additional recruiting or active studies for the same condition.

See all trials for Rare autonomic nervous system disorder →

← Back to all trials